With the ongoing focus on vaccine research due to the pandemic (e.g. mRNA), biotech stocks and their upside potential have caught investors’ attention. To find out which companies are leading the biotech sector, we looked at the universe of biotech pure plays (100+ companies) and identified which companies are the top performing biotech stocks (200% gain or more) since the end of the pandemic induced bear market (i.e. March 23, 2020). Companies with a market cap of less than $5 billion are not included since larger companies tend to have better access to resources which can help them better manage the uncertainties of clinical trials and regulatory risk. The resulting list contains seven biotech stocks with gains ranging from 225.3% to 1184.2% and an average of 470.3%.
Best Biotech Stocks Table Description: The following table includes and can be sorted on: company name, market cap, dividend yield, intraday stock price, and the intraday stock price percent change. This live table is updated throughout the trading day. To be alerted when our 2021 Best Biotech Stocks table is updated, sign up for our free Dogs of the Dow Newsletter.
Best Biotech Stocks FAQ
What are the best biotech stocks?
The seven best biotech stocks since the end of the 2020 bear market are Denali Therapeutics, Fate Therapeutics, Immunitybio, Moderna, Natera, Novavax, and TG Therapeutics.
Who is the largest biotech company?
Moderna is the largest biotech company on our seven Best Biotech Stocks List with a market cap over $60 billion.
Do biotech stocks pay dividends?
Some biotech stocks pay dividends, however, biotech stocks dividend yields are typically quite low. At this time, none of the seven best biotech stocks pays dividends.
Is there a biotech index?
Yes. The S&P Biotechnology Select Industry Index tracks US biotech stocks that are classified in the GICS biotechnology sub-industry. This biotech index started trading on January 27, 2006.
Is there a biotech ETF?
There are several ETFs that include biotech stocks in their portfolio but the SPDR S&P Biotech ETF specifically includes only biotech stocks. XBI was launched on January 31, 2006.